143 related articles for article (PubMed ID: 30105792)
21. Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study.
Biccler JL; Østgård LSG; Severinsen MT; Marcher CW; Møller P; Schöllkopf C; Friis LS; Bøgsted M; Jakobsen LH; El-Galaly TC; Nørgaard JM
Leukemia; 2018 Oct; 32(10):2263-2303. PubMed ID: 29476132
[No Abstract] [Full Text] [Related]
22. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.
Hou W; Zhang Y; Jin B; Cao W; Lu M; Yan L; Yang H; Tian X; Hou J; Fu J; Zhao H; Li H; Zhou J
Blood Cells Mol Dis; 2019 Nov; 79():102351. PubMed ID: 31400712
[TBL] [Abstract][Full Text] [Related]
23. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
[TBL] [Abstract][Full Text] [Related]
24. Update on the management of pediatric acute promyelocytic leukemia.
Feusner J; Gregory JJ
Clin Adv Hematol Oncol; 2006 Nov; 4(11):854-5; author reply 855-6. PubMed ID: 17193721
[No Abstract] [Full Text] [Related]
25. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia.
Lange AP; Lima AS; Lucena-Araujo AR; Jácomo RH; Melo RA; Bittencourt RI; Pasquini R; Pagnano K; Fagundes EM; Chauffaille ML; Chiattone CS; Sanz MA; Lo-Coco F; Grimwade D; Rego EM
Br J Haematol; 2018 Mar; 180(6):915-918. PubMed ID: 28025822
[No Abstract] [Full Text] [Related]
26. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
[TBL] [Abstract][Full Text] [Related]
27. Update on the management of pediatric acute promyelocytic leukemia.
Ribeiro R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
[No Abstract] [Full Text] [Related]
28. Acute promyelocytic leukemia: clinical findings and therapeutic results in 30 patients.
Runde V; Aul C; Landen H; Dokekias A; Fillet G; Schneider W
Haematol Blood Transfus; 1990; 33():346-50. PubMed ID: 2182428
[No Abstract] [Full Text] [Related]
29. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
de la Serna J; Montesinos P; Vellenga E; Rayón C; Parody R; León A; Esteve J; Bergua JM; Milone G; Debén G; Rivas C; González M; Tormo M; Díaz-Mediavilla J; González JD; Negri S; Amutio E; Brunet S; Lowenberg B; Sanz MA
Blood; 2008 Apr; 111(7):3395-402. PubMed ID: 18195095
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase: A case Series.
Shah G; Mikhail FM; Bachiasvili K; Vachhani P; Erba HP; Papadantonakis N
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):143-146. PubMed ID: 31629725
[TBL] [Abstract][Full Text] [Related]
31. Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4–7, 2010, Orlando, Florida.
Tallman MS; Lo-Coco F; Kwaan HC; Sanz MA; Gore SD
Clin Adv Hematol Oncol; 2011 Feb; 9(2 Suppl 3):1-16. PubMed ID: 22173578
[TBL] [Abstract][Full Text] [Related]
32. Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).
Hassan IB; Zaabi MRA; Alam A; Hashim MJ; Tallman MS; Kristensen J
Int J Hematol; 2017 Jul; 106(1):90-98. PubMed ID: 28293819
[TBL] [Abstract][Full Text] [Related]
33. Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis.
Abrahão R; Ribeiro RC; Malogolowkin MH; Wun T; Keegan THM
Haematologica; 2022 Mar; 107(3):733-736. PubMed ID: 34320784
[No Abstract] [Full Text] [Related]
34. Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009.
Fisher BT; Singh S; Huang YS; Li Y; Gregory J; Walker D; Seif AE; Kavcic M; Aplenc R
Pediatr Blood Cancer; 2014 Jan; 61(1):68-73. PubMed ID: 23868668
[TBL] [Abstract][Full Text] [Related]
35. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
36. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
[TBL] [Abstract][Full Text] [Related]
37. Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience.
Sobas M; Czyż A; Montesinos P; Armatys A; Helbig G; Hołowiecka A; Pluta A; Zarzycka E; Piątkowska-Jakubas B; Majcherek M; Lewandowski K; Gołos A; Paluszewska M; Podhorecka M; Oleksiuk J; Skręt A; Hawrylecka D; Guzicka-Kazimierczak RE; Wątek M; Gromek T; Charliński G; Grosicki S; Holojda J; Miśkiewicz W; Martinez-Cuadrón D; Sanz MA; Wróbel T; Wierzbowska A; Giebel S
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):105-113. PubMed ID: 31874794
[TBL] [Abstract][Full Text] [Related]
38. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
40. Acute promyelocytic leukemia: what is the new standard of care?
Watts JM; Tallman MS
Blood Rev; 2014 Sep; 28(5):205-12. PubMed ID: 25107311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
